The U.S. Department of Justice recently announced updates to its Evaluation of Corporate Compliance Programs (ECCP) guidance, including a new focus on artificial intelligence and other emerging technology. The ECCP remains an essential resource for compliance professionals in the health care industry and beyond, and these latest updates introduce yet more factors for consideration when designing, implementing, and testing a company’s compliance program.
Joey Burby and BJ Stieglitz share insights on the key takeaways from the updated ECCP guidance for companies and compliance professionals, with a focus on the three most notable new and updated areas: companies’ use of AI and other emerging technology, their policies surrounding whistleblowers, and use of data in connection with their compliance programs.
You can also learn more from our advisory: Compliance in the Age of AI: The DOJ Issues Updated ECCP Guidance.
Subscribe to Our Health Care Updates >
View More Healthy Bytes > | Return to Digital Transformation of Health Care >